Long Term Effects of Tillage and Nitrogen Source, Rate, and Placement on Grain Sorghum Production

jpa ◽  
1997 ◽  
Vol 10 (1) ◽  
pp. 141-146 ◽  
Author(s):  
P. R. Matowo ◽  
G. M. Pierzynski ◽  
D. A. Whitney ◽  
R. E. Lamond
1997 ◽  
Vol 48 (8) ◽  
pp. 1241 ◽  
Author(s):  
Holger Meinke ◽  
Malcolm Ryley

Until 1996 the disease ‘sorghum ergot’ (Claviceps africana and Claviceps sorghi) was unknown in Australia. Following an outbreak near Gatton, the disease was found throughout most of the sorghum-producing areas in Queensland within 4 weeks. A climatic risk analysis was conducted to assess the likely timing and frequencies of further outbreaks of the disease across the main sorghum-producing regions of Australia. Based on the information available, likely conditions that could lead to a disease outbreak were formulated and a computer program developed to interrogate an existing database of long-term, daily weather records. Case studies were conducted for 10 key sorghum-producing locations, ranging from Narromine in central New South Wales to Mareeba in far North Queensland and Kununurra in Western Australia. For grain sorghum production, crops flowering in January and February are unlikely to be affected, regardless of location. However, in up to 30% of years, late-sown grain sorghum crops and crops flowering before January could be affected, depending on climatic conditions prior to and around anthesis. The frequency and timing of these events differed strongly temporally and spatially and appeared highest in high rainfall years and in regions with relatively cooler temperatures and more frequent autumn rains. Hybrid seed production (i.e. breeding programs) and forage sorghum production are likely to be more affected due to their inherently low pollen generation, again with strong regional variation. Further applications of the methodology, such as the development of an early warning system, based on phases of the Southern Oscillation Index, are discussed.


Author(s):  
T. M. Seed ◽  
M. H. Sanderson ◽  
D. L. Gutzeit ◽  
T. E. Fritz ◽  
D. V. Tolle ◽  
...  

The developing mammalian fetus is thought to be highly sensitive to ionizing radiation. However, dose, dose-rate relationships are not well established, especially the long term effects of protracted, low-dose exposure. A previous report (1) has indicated that bred beagle bitches exposed to daily doses of 5 to 35 R 60Co gamma rays throughout gestation can produce viable, seemingly normal offspring. Puppies irradiated in utero are distinguishable from controls only by their smaller size, dental abnormalities, and, in adulthood, by their inability to bear young.We report here our preliminary microscopic evaluation of ovarian pathology in young pups continuously irradiated throughout gestation at daily (22 h/day) dose rates of either 0.4, 1.0, 2.5, or 5.0 R/day of gamma rays from an attenuated 60Co source. Pups from non-irradiated bitches served as controls. Experimental animals were evaluated clinically and hematologically (control + 5.0 R/day pups) at regular intervals.


Author(s):  
D.E. Loudy ◽  
J. Sprinkle-Cavallo ◽  
J.T. Yarrington ◽  
F.Y. Thompson ◽  
J.P. Gibson

Previous short term toxicological studies of one to two weeks duration have demonstrated that MDL 19,660 (5-(4-chlorophenyl)-2,4-dihydro-2,4-dimethyl-3Hl, 2,4-triazole-3-thione), an antidepressant drug, causes a dose-related thrombocytopenia in dogs. Platelet counts started to decline after two days of dosing with 30 mg/kg/day and continued to decrease to their lowest levels by 5-7 days. The loss in platelets was primarily of the small discoid subpopulation. In vitro studies have also indicated that MDL 19,660: does not spontaneously aggregate canine platelets and has moderate antiaggregating properties by inhibiting ADP-induced aggregation. The objectives of the present investigation of MDL 19,660 were to evaluate ultrastructurally long term effects on platelet internal architecture and changes in subpopulations of platelets and megakaryocytes.Nine male and nine female beagle dogs were divided equally into three groups and were administered orally 0, 15, or 30 mg/kg/day of MDL 19,660 for three months. Compared to a control platelet range of 353,000- 452,000/μl, a doserelated thrombocytopenia reached a maximum severity of an average of 135,000/μl for the 15 mg/kg/day dogs after two weeks and 81,000/μl for the 30 mg/kg/day dogs after one week.


2012 ◽  
Vol 43 (3) ◽  
pp. 42
Author(s):  
MITCHEL L. ZOLER
Keyword(s):  

VASA ◽  
2005 ◽  
Vol 34 (4) ◽  
pp. 243-249 ◽  
Author(s):  
Drinda ◽  
Neumann ◽  
Pöhlmann ◽  
Vogelsang ◽  
Stein ◽  
...  

Background: Prostanoids are used in the treatment of Raynaud’s phenomenon and acral perfusion disorders secondary to collagenosis. In subjective terms, intravenous administration of these agents produces success in more than 50% of patients. The therapeutic outcome of clinical administration of alprostadil or iloprost may vary from individual to individual. Patients and methods: The following variables were analysed in a cross-over study in 27 patients with collagenosis and Raynaud’s phenomenon: plasma viscosity and erythrocyte aggregation (rheological variables), partial pressure of oxygen and laser Doppler flowmetry in the finger region, and lymphocyte phenotyping and interleukin (IL) determinations (immunological variables). Results: Laser Doppler flowmetry revealed significant differences between patients with secondary Raynaud’s phenomenon and a control group of 25 healthy subjects. Laser Doppler readings did not change significantly as a result of the treatments. Therapy with iloprost produced a reduction in IL-1beta, L-selectin (CD 62 L) and IL-6. Conclusion: The change in immunological variables due to iloprost may explain the long-term effects of prostaglandins in the treatment of Raynaud’s phenomenon. From our results it is not possible to infer any preference for iloprost or alprostadil.


Sign in / Sign up

Export Citation Format

Share Document